Fundraising Fox
Mitsui Global Investment
Venture capitalMenlo Park · Pre-Seed–Late Stage · 12 people tracked
Also known as MITSUI & CO. GLOBAL INVESTMENT, INC. · Mitsui & Co. Global Investment, Inc. 東京支店
Find your way into Mitsui Global Investment
Each arrow is one introduction. Sign up to fill in the first one.
Ask Sameer Madan to introduce you to Caroline Pinkney
You →Sameer · together at Neura Health →Caroline
Ask Jamie Chen to introduce you to Kazufumi Nakamura
You →Jamie · together at Mahzi Therapeutics →Kazufumi
Ask Sam Okafor to introduce you to Yukitaka Kojima
You →Sam · together at EVP →Yukitaka
- Toshihiro Terada31 people can intro you
- Kinji Fuchikami2 people can intro you
- Reiko Namikawa2 people can intro you
Sign up to find every way you can get introduced to Mitsui Global Investment
- Your email: who you already know at Mitsui Global Investment, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Mitsui Global Investment team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
The firm positions itself as an investor that goes beyond financial backing, actively guiding entrepreneurs with strong business plans and ambitious goals. It partners with exceptional teams reinventing industries to improve human welfare worldwide, and emphasizes involvement in local communities alongside a global growth orientation. The firm highlights portfolio companies that have overcome setbacks and market challenges to grow stronger.
Source: firm website, verified Sep 29, 2026.
Team · 12 people
from the firm's website & public directories
What they invest in
from 28 of 62 portfolio companiesBiotech ×13AI & Machine Learning ×8Deep Tech ×7Healthtech ×7Digital Health ×5Enterprise Software ×5Medical Devices ×5Data & Infrastructure ×4
HQs:United States×27Japan×2Canada×1
Who they back
founder profiles across 22 portfolio companiesFounding team size:solo founder×92 founders×83 founders×44+ founders×1
Where their founders studiedfrom 17 founders with education data
Tel Aviv University ×3International Space University ×2Massachusetts Institute of Technology ×2The Hebrew University of Jerusalem ×2
What their founders studiedfrom 17 founders with field-of-study data
Life Sciences ×6Computer Science ×4Business & Management ×3Engineering ×2Finance & Accounting ×2Medicine ×2
Where their founders worked beforefrom 18 founders with career history
Google ×2NASA Ames Research Center ×2
Investments · 62 tracked
founders shown can be your intro pathBy year:2025 · 22024 · 12023 · 12021 · 12018 · 12017 · 12015 · 32014 · 22012 · 315 dated
Kaltura provides AI-powered video platforms for live and on-demand digital experiences that enable brands and organizations to engage audiences and achieve business goals.
AI & Machine LearningEnterprise SoftwareMedia & EntertainmentNew York, US
Ron Yekutiel(Founder)inShay David(Director)inEynav Azaria(Chief Product, Engineering and Marketing Officer)inNatan Israeli(Chief Customer and Commercial Officer)in
Co-investors.406 VenturesAvalon Ventures Management, LlcLuminari CapitalNGP CapitalRuna CapitalSapphire Ventures+5 more
Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.
BiotechHealthtechNew Haven, US
Stephen Uden(Founder)inMartin W. Mackay(Chairman of the Board of Directors)inJon(Chief Financial Officer)
Co-investors5AM VenturesCanaan PartnersConnecticut InnovationsF-Prime CapitalPivotal Life SciencesSolasta Ventures+1 more
Valens develops high-performance connectivity chipsets that are embedded in devices to support digital and connectivity experiences.
Deep TechHardwareMobility & TransportationSemiconductors
Co-investors10DAmiti VenturesAviv Venture CapitalF4 VenturesMagenta Venture PartnersMagma Venture Partners+2 more
Biotech developing small-molecule therapies for respiratory, inflammatory and autoimmune diseases, acquired by Boehringer Ingelheim.
BiotechSan Mateo, US
Peter McWilliams(Executive Officer, Director)Kevin Bacon(Executive Officer, Director)in
BoardFred Middleton(Director)Masaji Matsuoka(Director)in
Biotechnology company developing blood-brain-barrier-penetrating recombinant protein therapies for CNS disorders; acquired by JCR Pharmaceuticals in 2020.
Ruben Boado(Founder)in
Co-investorsBoehringer Ingelheim Venture Fund
Israeli fabless semiconductor company making vehicle-to-everything (V2X) communication chipsets for connected and autonomous vehicles.
Co-investorsAmiti VenturesFraser McCombs CapitalMagenta Venture PartnersMagma Venture PartnersManiv MobilitySamsung Catalyst Fund+5 more
Ellipsis builds AI agents that handle repetitive engineering tasks like code review, production debugging, and standup reports, letting teams focus on higher-value work.
AI & Machine LearningDeveloper ToolsEnterprise SoftwareNew York City, US
Hunter Brooks(Co-founder & CEO)in
Co-investorsPioneerTranspose Platform ManagementY CombinatorAmino CapitalCRV (Charles River Ventures)Four Cities+4 more
-2.png)
Ellipsis Health builds Sage, an AI voice agent designed to support healthcare organizations by handling patient interactions and expanding clinical capacity.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Mainul Islam(Executive Officer, Director)Mainul Mondal(Founder & CEO)inMichael Aratow(Co-Founder & Chief Medical Officer)in
BoardMarie Hurabiell(Director)
Co-investorsAble PartnersAIX VenturesAlumni VenturesCity LightCVS Health VenturesE12 Venture Capital, Llc+7 more
GoSecure is a Managed Detection and Response (MDR) cybersecurity provider based in Montreal and San Diego.
San Diego, US
Co-investorsEastward Capital PartnersRazor's Edge VenturesShield CapitalYaletown PartnersEdge
Mahzi develops therapies for patients with under-diagnosed and under-served rare genetic neurodevelopmental disorders, working with patient and family groups, academic researchers, and industry partners.
BiotechHealthtechSouth San Francisco, US
Yael Weiss(Executive Officer, Director)in
BoardCamille Samuels(Director)inMarten Steen(Director)inShalini Sharp(Director)inStephen Farr(Director)
Co-investorsDroia VenturesHBM Healthcare InvestmentsHBM PartnersHealthCapVenrockVenrock Associates
Davis, California developer of biological crop protection, plant health and waterway treatment products, formerly NASDAQ: MBII.
AgTechDavis, US
Pamela G. Marrone(Executive Officer, Director)James B. Boyd(Executive Officer)Linda V. Moore(Executive Officer)inDon Glidewell(Executive Officer)inJulie I Morris(Executive Officer)inChris Hildreth(Executive Officer)in
Co-investorsBand of Angels
MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.
BiotechDigital HealthHealthtechMedical DevicesLexington, US
John Rogers(Director)David Icke(Executive Officer, Director)Alice Sansone(Executive Officer)Steven N. Tannenbaum(Executive Officer)Scott D. Pomerantz(Executive Officer, Director)
BoardMarc Singer(Director)in
Co-investorsBraemar Energy VenturesOUP (Osage University Partners)Windham Capital PartnersAberdare VenturesNorth Bridge Venture Partners & Growth Equity
Neura Health provides telemedicine video visits with board-certified neurologists for conditions including migraine, epilepsy, sleep disorders, tremor, concussion, and stroke.
Digital HealthHealthtechNew York, US
Sameer Madan(Founder)inElizabeth Burstein(Founder)in
Co-investorsCorrelation VenturesE12 Venture Capital, LlcEsplanade VenturesKoch Disruptive TechnologiesNext Play VenturesPear VC+2 more
OpenX is a supply-side platform (SSP) for digital advertising that uses AI, data leadership, and proprietary identity technology to manage ad inventory and targeting.
AdTechAI & Machine LearningNot specified on page, US
DAMON REEVE(Director)inTIM CADOGAN(Executive Officer, Director)inJoshua Metzger(Interim CEO)in
BoardNINO MARAKOVIC(Director)inANDREW Scott BRACCIA(Director)BERNARD DALLE(Director)in
Co-investorsChartline Capital PartnersDag VenturesIndex VenturesLocalGlobePresidio VenturesSapphire Ventures+7 more
Pica8 develops PICOS, a Linux-based open network operating system, and the AmpCon controller for white box enterprise networks.
Palo Alto, US
Chunyi (James) Liao(Executive Officer, Director)
BoardTerry Chen(Director)inChen-Wen Tarn(Director)Mike Splinter(Director)
Co-investorsVantagePoint Capital PartnersWI Harper Group
ProteinSimple developed instruments and consumables for protein analysis; acquired by Techne/Bio-Techne for $300M in 2014.
Co-investorsLatterell Venture PartnersThe Vertical Group
Proterra designs and manufactures zero-emission battery systems for commercial vehicles.
CleantechHardwareMobility & TransportationGreenville, US
Ryan Popple(Executive Officer, Director)Eric McCarthy(Executive Officer)C. W. Plummer, Jr.(Executive Officer)Dave Rich(Executive Officer)
BoardRob Johnson(Director)Michael Smith(Director)
Co-investorsBMW i VenturesConductive VenturesConstellation Technology VenturesEnergy Impact PartnersEvolution VC PartnersObvious Ventures+7 more
QD Laser develops, manufactures, and sells high-efficiency semiconductor lasers for telecommunications and industrial use, as well as visual-information devices.
Deep TechHardwareMedical DevicesSemiconductorsYokohama, JP
Mitsuru Sugawara(Founder)in菅原 充(Founder & Chief Technology Advisor)大久保 潔(President & Representative Director)
Co-investorsBeyond Next VenturesMIRAI SOUZOUNTT DOCOMO VenturesOita Venture CapitalSMBC Venture CapitalUntroD Capital+4 more
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Co-founder)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Director, Executive Officer, Promoter)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in
Co-investorsDolby Family VenturesDroia VenturesInkefMC Healthcare VenturesMission BiocapitalSanofi Ventures+7 more
Reunion Neuroscience is a clinical-stage biopharmaceutical company developing serotonergic psychedelic therapies for mental health conditions such as postpartum depression, adjustment disorder, and generalized anxiety disorder.
BiotechDigital HealthMental HealthMorristown, US
Sahil V. Kirpekar(President and CEO)inGregory Mayes(Executive Officer, Director)Ellen Lubman(Director)Mark Pollack(Executive Officer)inNathan Bryson(Executive Officer)inMark Theeuwes(Executive Officer)in
Co-investorsFemHealth VenturesMPM BioImpactPalo Santo VCNovo Holdings
Rhino builds a system of record for enterprise business logic, rules, and decisions that are typically scattered across legacy systems and processes.
AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareAlexandria, US
Adam Branch(Executive Officer, Director, Promoter)in
BoardHarrison Touati(Director)Jon Galitzer(Director)
Co-investorsKoch Disruptive TechnologiesLionBirdAlleyCorpGaingelsQiming Venture Partners USATiger Global Management+1 more
__Twitter.png)
Rhino Federated Computing provides enterprise software infrastructure enabling organizations to run AI, analytics, and data workflows across distributed data environments while preserving privacy and security.
AI & Machine LearningData & InfrastructureEnterprise SoftwareBoston, US
Dr. Ittai DayaninIttai Dayan(Dr.)inYuval Baror(Founder)inChristopher Laws(Executive Officer)
BoardEdward Michael(Director)inIvneet Bhullar(Director)in
Co-investorsAlleyCorpE12 Venture Capital, LlcFusionLionBirdQiming Venture Partners USAAlley Robotics Ventures+2 more
Monmouth Junction, US
David C. Aldous(Executive Officer, Director)in
BoardWilliam Wiberg(Director)Jamie Kiggen(Director)Daniel Carter(Director)inMichael Zak(Director)David J. Tippeconnic(Director)
Co-investorsAramco VenturesSaudi Aramco Energy VenturesThe Blackstone Group
JS Communications provides network integration services, infrastructure solutions, and security technologies for enterprise IT systems.
Cloud ComputingCybersecurityData & InfrastructureEnterprise SoftwareIoTTokyo, JP
William Kish(Executive Officer, Director)Victor Shtrom(Executive Officer)Selina Lo(Executive Officer, Director)James Hennessy(Executive Officer)愛須 康之(代表取締役会長 (Representative Director & Chairman))渡邉 辰夫(代表取締役社長 (Representative Director & President))
Co-investorsMobile Internet Capital, Inc.WingSequoia CapitalSutter Hill Ventures
Sirrus develops chemical building blocks based on patented methylene malonate monomers and oligomeric crosslinkers that polymerize anionically at ambient temperatures.
Advanced ManufacturingCleantechDeep TechNew MaterialsLoveland, US
Bernard Malofsky(Executive Officer)inJeff Uhrig(President, Chief Executive Officer, Secretary and Treasurer)inRobert Smith(Executive Officer)Adam Malofsky(Director)
BoardWilliam Lese(Director)inDoug Cameron(Director)
Co-investorsBraemar Energy VenturesCincyTechArsenal
Spire operates a constellation of nanosatellites that collect granular Earth and environmental data from orbit, providing analytics for climate, logistics, and community protection.
Climate TechData & InfrastructureLogistics & Supply ChainSpace TechVienna, Virginia, US
Peter Platzer(Executive Chairman)inJeroen Cappaert(Founder)inJoel Spark(Founder)inTheresa Condor(Chief Executive Officer)inCelia Perez Pelaz(Executive Officer)Thomas Krywe(Executive Officer)in
Co-investorsBessemer Venture PartnersEvolution VC PartnersExpon CapitalFresco CapitalGen CapitalGPO Fund+11 more
Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging.
AI & Machine LearningBiotechMedical Devices
Frank Li(Founder & CEO)Christian Elabd, PhD(Head of Biology)
Co-investorsAIX VenturesFoothill VenturesAxial VCBoxOne VenturesCaffeinated CapitalDimension Capital+1 more
Svante builds filters and modular rotary contactor machines that capture and remove CO2 from industrial emissions and directly from the air.
CleantechClimate TechDeep TechEnergyNew MaterialsBurnaby, CA
Matthew Stevenson(Executive Officer)inClaude Letourneau(President & CEO)
BoardMarc Van Den Berg(Director)Roger Strauch(Director)inDamien Vacherot(Director)Laura Boudreau(Director)
Co-investorsChrysalixThe Roda GroupChevron Technology VenturesMitsui & CoTemasekBay Bridge Ventures Climate+5 more
Tacit Therapeutics develops RNA-based gene therapy approaches by redirecting cellular splicing processes to repair mutated genes.
BiotechDeep TechHealthtechSan Francisco, US
Co-investorsEisai Innovation, Inc.KdT VenturesMichigan Capital Network
Therini Bio is a biotechnology company developing fibrin-targeting therapeutics to treat neurological and ophthalmological diseases, leveraging scientific discoveries in neurovascular and neuroimmune mechanisms of disease.
BiotechDigital HealthHealthtechMedical DevicesSacramento, US
Katerina Akassoglou(Scientific Founder, Director of the Center for Neurovascular Brain Immunology and Professor of Neurology at UCSF and Gladstone Institutes)inKaterina Akassoglou, PhD(Scientific Founder)Leslie Schulze(Executive Officer)Tara Nickerson(Executive Officer, Director)in
BoardOlga Danilchanka(Director)inLaia Crespo-Martin(Director)
Co-investorsMRL Ventures FundSanofi VenturesSV Health InvestorsAngelini VenturesDementia Discovery FundDolby Family Ventures+2 more
Waypoint Bio uses artificial intelligence, computer vision, and pooled screening to conduct deep phenotyping across thousands of cell therapy designs, enabling the discovery and optimization of superior cell therapy candidates for development.
AI & Machine LearningBiotechDeep Tech
Xinchen Wang, Ph.D.(Co-founder & CEO)David Phizicky, Ph.D.(Co-founder & CSO)Xinchen Wang(Founder)in
Co-investorsAmplify PartnersFifty YearsHummingbird VenturesMBX CapitalRecode VenturesVillage Global+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ActimisArmaGenBeceemBioelectron Technology CorpBionova Pharmaceuticals LimitedBoston Biomedical IncChange Healthcare CorpCipiaContinuumrx ServicesConvenient Power LimitedEnsemEtonenet IncGladd Inc Fka Glamour Sales Holding LtdGobalto IncHainan Hailing Pharmaceutical LimitedHalationIat Automobile TechnologyLeash LaboratoriesLeyou IncNapaJen Pharma, Inc.NvascNxthera IncOn Chip BiotechnologiesPinnacle EnginesRedwood Systems IncS*BIOSbio Pte LtdSilk Fka Kaminario IncSix Rooms HoldingsSymic BiomedicalVirident
Exits · 29
6 IPOs · 23 acquisitions · showing 5KalturaNASDAQ: KLTRRallybio, LLCNASDAQ: RLYBValens (NYSE: VLN)NYSE: VLNMC10acq. by MedidataRedwood Systems Incacq. by CommScope
Portfolio news
latest coverage across their companiesWaypoint Bio · finsmes.com · Jun 2, 2026
OpenX · openx.com · Jan 14, 2026
Stately Bio · finsmes.com · May 1, 2025
Frequently asked questions
- How many investments has Mitsui Global Investment made?
- Mitsui Global Investment has 62 tracked investments, 29 of which have exited, including 3 dated in the last 24 months.
- What stage does Mitsui Global Investment invest at?
- Mitsui Global Investment invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Mitsui Global Investment's typical check size?
- Mitsui Global Investment typically writes checks of $500K – $10M.
- What sectors does Mitsui Global Investment focus on?
- Mitsui Global Investment focuses on AI & Machine Learning, Biotech, Cleantech, Consumer, Data & Infrastructure, Energy, Enterprise Software, FoodTech, Hardware, Healthtech, Medical Devices, New Materials, SaaS, Sector Agnostic, Semiconductors.
- Where is Mitsui Global Investment located?
- Mitsui Global Investment is headquartered in Menlo Park, US.
- Who does Mitsui Global Investment co-invest with?
- Mitsui Global Investment most often shares deals with Dolby Family Ventures, E12 Venture Capital, Llc, Magma Venture Partners, among 110 tracked co-investors.
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Chuangdongfang (创东方) is a Shenzhen-based investment firm focused on equity investment in technology and innovation-driven enterprises, engaging in venture, M&A, and industrial investment.
SBI Investment Korea is a Korean asset management firm within the SBI Group that operates venture capital and private equity funds, positioning itself as a 'New Industry Creator'.
VenturEast is one of India's longest-standing venture capital fund managers, investing since 1997 and managing over $325 million across more than 100 investments in technology, healthcare, and clean environment.
IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.